Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health monitoring in resource-limited settings news

Show

From To
Xpert testing to find TB in people with advanced HIV at diagnosis saves lives, study finds

A study reported in Clinical Infectious Diseases this week confirms that patients newly diagnosed with HIV who were screened for TB with Xpert technology had higher survival rates in the year that followed than those screened with a point-of-care test using flourescent light-emitting microscopy.

Published
08 April 2019
From
Science Speaks
Are CD4 counts still useful in the 'treat all' era?

CD4 cell testing before starting treatment is still essential even in the era of 'treat all' guidelines, two studies from southern Africa presented at the Conference on

Published
08 March 2019
By
Keith Alcorn
Point-of-care viral load testing improves treatment outcomes and retention in care

Same-day provision of results from a point-of-care viral load test – rather than waiting weeks for laboratory results to be collected – resulted in a 14% improvement

Published
05 March 2019
By
Roger Pebody
Viral load monitoring motivates HIV treatment adherence in eSwatini

The treat-all policy will only succeed if people keep taking their HIV treatment. It is important to motivate people who started treatment while they were still feeling well. 

Published
24 February 2019
From
AVERT
Back to the future with CD4 testing: Improving HIV care in low- and middle-income countries

A practical resource-based public health approach for the rapid initiation of antiretroviral therapy in HIV-infected individuals living in low- and middle-income countries could save thousands of lives, according to an Essay published January 15 in the open-access journal PLOS Medicine by Mark Tenforde of the University of Washington School of Medicine, and colleagues.

Published
16 January 2019
From
Science Daily
Drug resistance accumulates fast in people with low but detectable viral loads, Kenyan study finds

A study measuring HIV drug resistance at two timepoints in Kenyan patients on second-line, protease inhibitor-based regimens has found very high levels of drug resistance in people with

Published
22 October 2018
By
Gus Cairns
Access to on-the-spot testing led to improved rates of treatment for infants with HIV

Tests to detect HIV in infants conducted at health facilities where they received care led to a significant increase in the percentage of infants with the virus given access to life-saving treatment, compared to tests analyzed in central laboratories, according to a report in Clinical Infectious Diseases.

Published
22 August 2018
From
Science Speaks
Price Of HIV Viral Load Test Falls, Raising Hopes In Global AIDS Fight

The Clinton Health Access Initiative, along with several other development agencies, has brokered an agreement to make routine HIV tests more accessible. They're aiming to make HIV viral load tests available for $12 a piece, slashing the price in some markets by more than 50 percent.

Published
02 August 2018
From
NPR
Hologic's Global Access Initiative Increases Availability of Diagnostic Testing in Resource-Limited Countries

Hologic, Inc. announced today the launch of the new Hologic Global Access Initiative, in partnership with the Clinton Health Access Initiative (CHAI) and MedAccess (backed by the U.K. government), to increase affordable access to molecular testing for HIV, hepatitis B and C (HBV and HCV) and human papillomavirus (HPV) in nearly 50 nations around the world. These countries, primarily across Africa and Southeast Asia, make up 90 percent of the HIV disease burden globally.

Published
25 July 2018
From
Hologic press release
The “Undetectable = Untransmittable” message goes global: I=I, N=N and B=B

In Guatemala, the slogan is “Indetectable = Intransmisible” (I=I); in the Netherlands, it’s “Niet meetbaar = Niet overdraagbaar” (N=N); and in Turkey, “Belirlenemeyen = Bulaştırmayan” (B=B). One of

Published
23 July 2018
By
Roger Pebody
← First12345...17Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.